Project Grant R13HD120008
- This Project Grant award of $324,883 from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) will fund a pilot trial to develop and test an intervention to support initial type 2 diabetes (T2D) self-management among younger adults with children. The key objective is to identify effective behavior change strategies that can improve early glycemic outcomes and influence long-term diabetes-related health, especially for the younger adult population...
- The University of Pittsburgh was awarded a $521,829 Project Grant under the National Institute of Diabetes and Digestive and Kidney Diseases' (NIDDK) Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on the role of prolactin receptor (PRLR) signaling in the liver in regulating maternal metabolism during pregnancy. The project aims to characterize the hepatic PRLR signaling pathway and determine its contribution to maintaining normal energy...
- This $731,071 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to address challenges that prevent the provision of guideline-recommended diabetes care in the United States. The project will leverage real-world datasets on 17.4 million people with diabetes to: Describe differences in care receipt by individual, neighborhood, and insurance characteristics (Aim 1);...
- The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $313,955 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to Malama Health, Inc. of Redwood City, CA. The grant aims to develop a specialized risk-stratification platform and tailored diabetes prevention program for postpartum women with a history of gestational diabetes mellitus (GDM) to reduce their progression to type 2 diabetes. This project seeks to address...
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $549,125 to Rutgers, The State University of New Jersey to conduct a hybrid Type II effectiveness-implementation randomized controlled trial (RCT) for the "Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD)" program. The MOM-HD program aims to improve the management of hypertensive disorders and...
- This Project Grant award of $714,440 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a research study to advance precision diabetes medicine. The key objectives are to: Define subphenotypes of prediabetes and early type 2 diabetes based on underlying metabolic physiology, including insulin resistance, beta-cell function, incretin effect, and hepatic insulin resistance. Evaluate...
- This $147,459 federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), supports research to address racial and ethnic disparities in diabetes risk after varying glycemia levels during pregnancy. The research will focus on understanding whether future diabetes risk after gestational diabetes mellitus (GDM) and gestational glucose intolerance (GGI) differs across...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $167,864 to The General Hospital Corporation, doing business as Massachusetts General Hospital, to conduct a mixed-methods study on adapting and developing a diabetes self-management education and support (DSMES) intervention for people with type 2 diabetes experiencing food insecurity. The key objectives of the...
- This $310,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a feasibility study for an adaptive intervention to improve food security and maternal-child health. The study aims to determine the feasibility of recruitment and retention, as well as the potential effectiveness of interventions, including WIC referrals, care navigation,...
- This $143,346 project grant was awarded on July 15, 2025 by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which administers the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will be used by Vanderbilt University Medical Center (VUMC) to conduct research with the following objectives: Apply machine learning models to electronic health records to predict excessive and inadequate gestational weight gain. Examine the...
FROM LAB TO LABOR: ADVANCING DIABETES PREGNANCY CARE - ABSTRACT THE GLOBAL RISE IN OBESITY AND TYPE 2 DIABETES HAS LED TO AN INCREASE IN PREGESTATIONAL DIABETES, SIGNIFICANTLY RAISING RISKS DURING PREGNANCY. UNCONTROLLED HYPERGLYCEMIA IS TERATOGENIC, RESULTING IN ADVERSE MATERNAL AND FETAL OUTCOMES, WITH DIABESITY BEING A CRITICAL AREA OF FOCUS FOR THE DIABETES IN PREGNANCY STUDY GROUP OF NORTH AMERICA (DPSG-NA). SINCE ITS INCEPTION IN 1997, DPSG-NA HAS AIMED TO IMPROVE PREGNANCY OUTCOMES IN DIABETES BY ADVANCING RESEARCH, SHAPING MEDICAL POLICIES, AND INFLUENCING PROFESSIONAL PRACTICES. THE BIENNIAL DPSG-NA MEETINGS HAVE DRIVEN RESEARCH PROGRESS, ADDRESSING CONTROVERSIES IN GDM SCREENING, DIAGNOSIS, AND TREATMENT, AND HAVE EVOLVED TO INCLUDE DISCUSSIONS ON CONGENITAL MALFORMATIONS, PERINATAL MORTALITY, AND COST-EFFECTIVE DIABETES MANAGEMENT. THE 18TH BIENNIAL MEETING IN 2025, TITLED FROM LAB TO LABOR: ADVANCING DIABETES PREGNANCY CARE, WILL EMPHASIZE NUTRITION IN PREGNANCY AND AIM TO SUPPORT EARLY- STAGE INVESTIGATORS (ESIS) IN THE FIELD. KEY OBJECTIVES OF THE MEETING INCLUDE: 1) SUPPORTING ESIS THROUGH PLANNING AND NETWORKING OPPORTUNITIES, EXPOSING ESIS TO GROUNDBREAKING WORK, FOSTERING NEW PROJECTS AND ADDRESSING KNOWLEDGE GAPS IN DIABETES AND PREGNANCY RESEARCH, 2) PRESENTING OF THE LATEST RESEARCH IN DIABETES AND NUTRITION IN PREGNANCY BY WELL-ESTABLISHED INVESTIGATORS, FACILITATING KNOWLEDGE EXCHANGE AND FOSTERING COLLABORATION AMONG EARLY-CAREER AND EXPERIENCED INVESTIGATORS, AND 3) DISSEMINATING FINDINGS, ESPECIALLY TO PRACTITIONERS TREATING UNDERSERVED POPULATIONS, ENSURING A COMPREHENSIVE UNDERSTANDING OF CHALLENGES AND SOLUTIONS IN MANAGING DIABETES IN DIVERSE POPULATIONS. EFFORTS TO ENCOURAGE PARTICIPATION FROM UNDERSERVED REGIONS WILL ENHANCE THE SCOPE OF DISCUSSIONS, WHILE COLLABORATIVE RESEARCH PRESENTATIONS AND ABSTRACT SUBMISSIONS WILL STIMULATE FURTHER ADVANCEMENTS IN THE FIELD. THE MEETING'S OUTCOMES WILL BE SHARED THROUGH PEER-REVIEWED PUBLICATIONS, CONTRIBUTING TO A ROBUST RESEARCH COMMUNITY FOCUSED ON IMPROVING OUTCOMES FOR PREGNANCIES COMPLICATED BY DIABETES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $10.0k | 8/22/25 |